Quantum Dot Nanoparticle Silica Shell Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Quantum dot-containing nanoparticles face challenges in maintaining stability and controlling particle size while exhibiting excellent optical properties, due to low capping density and instability when protected with silica, leading to deterioration of optical properties.

Innovation Solution

A quantum dot-containing nanoparticle structure comprising a core, quantum dot part, shell, and support part, where the support part is formed by a linker with functional groups bonded to the core and shell, enhancing capping density and stability, and a method involving surface modification, quantum dot binding, and silica precursor reaction to form multiple silica shell layers, allowing for controlled particle size and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If quantum dot-containing nanoparticles are capped with silica to protect from moisture and oxygen, then stability is improved, but capping density is low and particle size control is difficult

Engineering Contradiction:
ImprovestabilityVSAvoidparticle size control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent divides the capping structure into multiple discrete silica shell layers surrounding the quantum dot core. This segmented approach allows each layer to be formed and controlled independently, enabling precise particle size control while achieving high cumulative capping density through multiple layers rather than a single dense layer.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from a single-layer capping approach to a multi-layer shell structure, adding the dimension of layer number and thickness control. This enables independent optimization of capping density (through layer number) and particle size (through layer thickness), resolving the contradiction between these two parameters.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If capping density is increased to improve stability, then optical properties are maintained, but particle size control becomes more difficult

Engineering Contradiction:
ImprovestabilityVSAvoidparticle size control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The capping density is achieved through multiple discrete silica layers rather than a single dense layer. Each layer contributes to the cumulative capping density, allowing high stability to be achieved while maintaining control over individual layer thickness and overall particle size.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies multiple successive capping layers, using partial action in each step to build up the total capping density. This incremental approach allows precise control of particle size at each stage while achieving the required stability through the accumulation of multiple layers.

Inventive Principle:
Principle #16Partial or excessive action

3Reliability

If quantum dots are evenly distributed on nanoparticle surface, then optical properties are improved, but capping density remains low

Engineering Contradiction:
Improveoptical propertiesVSAvoidcapping density
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent distributes quantum dots across multiple discrete silica layers rather than concentrating them on a single surface. This segmentation allows even distribution of quantum dots throughout the shell structure, maintaining excellent optical properties while achieving high cumulative capping density through the multi-layer architecture.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent moves from two-dimensional surface distribution to three-dimensional distribution across multiple layers. This adds the dimension of radial distribution, allowing quantum dots to be evenly distributed throughout the shell volume while achieving high capping density through the cumulative effect of multiple layers.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The enhanced capping density and stability of the nanoparticles result in excellent optical properties and the ability to control particle size, making them suitable for biotechnological applications such as biological detection and labeling.

Implementation Method 1

a material exhibiting a quantum confinement effect in which a luminous wavelength differs from that of a bulk state since the electron motion characteristics in the semiconductor material in the bulk state become further restricted when it becomes small to a certain size or less

Methodology Applied
Scientific EffectQuantum confinement effect:

Implementation Method 2

If this quantum dot reaches the energy excited state by receiving light from an excitation source, it autonomously emits energy according to a corresponding energy band gap

Methodology Applied
Scientific EffectPhotoluminescence: Photoluminescence

Data Source

PatentUS11851592B2Quantum dot-containing nanoparticle and method for manufacturing same
Publication Date: 2023.12.26 BIOSQUARE INC
  • US11851592B2 patent drawing
  • US11851592B2 patent drawing
  • US11851592B2 patent drawing

AI summary

The present invention relates to a quantum dot-containing nanoparticle comprising: a core part; a quantum dot part bound to a surface of the core part; a shell part for protecting the core part and the quantum dot part; and a support part for supporting the binding of the core part and the shell part, wherein the nanoparticle exhibits a high occupied area and stable binding, thereby exhibiting improved luminous efficiency (QY) and brightness when detecting a biological sample (biomolecule).